SCHEMBL844993

SCHEMBL844993

CC(=O)N1C[C@H](OC(C)(C)C)C[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C[C@@H](OC(C)(C)C)CN3C(=O)Cc3cccnc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 5/20 0.40
ANPEP P15144 3/20 0.40
PAX8 Q06710 1/20 0.38
S1PR1 P21453 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
HRH3 Q9Y5N1 2/20 0.37
CYP2C9 P11712 2/20 0.36
THRB P10828 1/20 0.35
MMP9 P14780 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
NAMPT P43490 1/20 0.35
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845345 0.97 PAX8 (0.40) MMP2PAX8S1PR1CYP3A4CYP2D6
SCHEMBL10119509 0.89 PAX8 (0.35) MMP2ANPEPPAX8S1PR1CYP3A4
SCHEMBL845778 0.86 CTSS (0.43) MMP2ANPEPS1PR1CYP3A4CYP2D6
SCHEMBL2197099 0.81 RXFP3 (0.38) S1PR1CYP3A4CYP2D6HRH3CYP2C9
SCHEMBL845401 0.79 ALDH1A1 (0.45) PAX8HRH3CYP2C9KMT2AMEN1
SCHEMBL873144 0.78 HDAC8 (0.37) MMP2ANPEPS1PR1CYP3A4CYP2D6
SCHEMBL845491 0.77 POLB (0.55) KMT2AMEN1
SCHEMBL845351 0.77 ITGB1 (0.41) PAX8HRH3CYP2C9THRBKMT2A
SCHEMBL845628 0.76 KMT2A (0.41) CYP2C9KMT2AMEN1NPC1RAB9A
SCHEMBL13272453 0.75 HDAC8 (0.37) S1PR1CYP3A4CYP2D6CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed